Medidata (Medidata AI / Link)
Overview
Clinical trial technology leader whose Medidata Link solution connects patient-level clinical trial data with real-world data via tokenization-based linkage, enabling long-term outcomes follow-up and hybrid evidence generation. Part of Dassault Systemes, it also offers AI-driven synthetic control arm and analytics products.
Notable
Acquired by Dassault Systemes in 2019 for $5.8B; partnered with TriNetX and Datavant to integrate RWD into clinical development.
Key services
- Medidata Link trial-to-RWD linkage
- tokenization partner integrations
- synthetic/external control arms (Medidata AI)
- clinical data platform
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Medidata (Medidata AI / Link)? Share your experience in a short, confidential interview.
Share your experienceSources
- https://www.medidata.com/en/clinical-trial-products/medidata-ai/real-world-data/link-real-world-and-clinical-trial-data/
- https://www.3ds.com/newsroom/press-releases/medidata-launches-medidata-link-first-centralized-technology-solution-connect-and-analyze-patient-level-clinical-trial-data-and-real-world-data
- https://www.datavant.com/press-release/medidata-trinetx-and-datavant-partner-to-enable-seamless-integration-of-real-world-data-in-clinical-development